: Association of Epstein-Barr virus with undifferentiated gastric carcinoma https://www.selleckchem.com/products/Bortezomib.html with intense lymphoid infiltration. Am J Pathol 1991, 139: 469–474.PubMed 3. Shibata D, Weiss LM: Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992, 140: 769–774.PubMed 4. Zur Hausen A, van Rees BP, van Beek J, et al.: Epstein-Barr virus in gastric
carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. J Clin Pathol 2004, 57: 487–491.CrossRefPubMed 5. Takada K: Epstein-Barr virus and gastric carcinoma. Mol Pathol 2000, 53: 255–261.CrossRefPubMed 6. Herrmann K, Niedobitek G: Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 2003, 199: 140–145.CrossRefPubMed 7. zur Hausen A, Brink AA, Craanen ME, et al.: Unique transcription
pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000, 60: 2745–2748.PubMed 8. zur Hausen A, van Grieken NC, Meijer GA, et al.: Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 2001, 121: 612–618.CrossRefPubMed 9. Uozaki H, Fukayama M: Epstein-Barr Virus and Gastric Carcinoma – Viral KU-60019 Carcinogenesis through Epigenetic Mechanisms. Int J Clin Exp Pathol 2008, 1 (3) : 198–216.PubMed 10. Ott G, Kirchner T, Muller-Hermelink HK: Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression Aldol condensation in different types of gastric carcinoma. Histopathology 1994, 25: 323–329.CrossRefPubMed 11. Imai S, Koizumi S, Sugiura M, et al.: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994, 91: 9131–9135.CrossRefPubMed 12. Yamamoto N, Tokunaga M, Uemura Y, et al.: Epstein-Barr virus and gastric remnant cancer. Cancer 1994, 74: 805–809.CrossRefPubMed 13. Gulley ML, Pulitzer DR, Eagan PA, et al.: Epstein-Barr virus infection is an early event in gastric carcinogenesis and is R406 clinical trial independent of bcl-2 expression and p53 accumulation.
Hum Pathol 1996, 27: 20–27.CrossRefPubMed 14. Yanai H, Takada K, Shimizu N, et al.: Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 1997, 183: 293–298.CrossRefPubMed 15. Yanai H, Murakami T, Yoshiyama H, et al.: Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. J Clin Gastroenterol 1999, 29: 39–43.CrossRefPubMed 16. Middeldorp JM, Brink AA, Brule AJ, et al.: Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 2003, 45: 1–36.CrossRefPubMed 17. World Health Organisation: Classification of tumours. Pathology and genetics, tumours of the digestive system. Lyon: IARC; 2000. 18.